Zhili Qiao
1 appearance in the program
Sessions & presentations
PS40: Integrating AI/ML to Advance Drug Development: Innovative Methodologies and Regulatory Perspectives
Presenting Author
Presentation: Artificial Intelligence (AI) vs. Clinical Endpoint Committee (CEC) Endpoints Adjudication: Are We There Yet?
Parallel · Fri, Sep 26 , 10:45 AM